Published in Am J Cardiol on September 01, 1994
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Europace (2010) 1.43
Present treatment options for atrial fibrillation. Postgrad Med J (2003) 1.37
The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation. Indian Pacing Electrophysiol J (2009) 1.21
Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation. Heart (2000) 0.99
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart (1999) 0.82
[Pharmacological cardioversion of atrial fibrillation]. Z Kardiol (2005) 0.81
Pharmacological management of atrial fibrillation: one, none, one hundred thousand. Cardiol Res Pract (2011) 0.80
Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study. Clin Res Cardiol (2010) 0.79
Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation. Eur J Clin Pharmacol (2004) 0.77
Effects of propafenone on K currents in human atrial myocytes. Br J Pharmacol (1999) 0.77
Atrial-selective sodium channel block by dronedarone: sufficient to terminate atrial fibrillation? Naunyn Schmiedebergs Arch Pharmacol (2011) 0.76
Electrophysiological Changes of the Atrium in Patients with Lone Paroxysmal Atrial Fibrillation. J Atr Fibrillation (2010) 0.75
Atrial fibrillation. J Biomed Res (2013) 0.75
Ranolazine for Atrial Fibrillation: Too Good to be True? J Atr Fibrillation (2010) 0.75
Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04
Seizure-induced brain lesions: a wide spectrum of variably reversible MRI abnormalities. Eur J Radiol (2013) 2.65
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J (2004) 1.66
Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol (1992) 1.66
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J (2002) 1.45
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42
Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. Europace (1999) 1.41
Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation. Heart (2011) 1.39
[Diagnostic contribution of magnetic resonance in clinically suspected arrhythmogenic dysplasia of the right ventricle]. G Ital Cardiol (1996) 1.39
Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina. Circulation (1979) 1.20
Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome. Clin Endocrinol (Oxf) (2000) 1.17
Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthritis Cartilage (2007) 1.16
Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. J Med Genet (2003) 1.13
Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12
Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol (2005) 1.12
Sequence organization of the circular plasmid pKD1 from the yeast Kluyveromyces drosophilarum. Nucleic Acids Res (1986) 1.11
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol (1994) 1.09
Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J (2001) 1.09
Analysis of a 1.6-micron circular plasmid from the yeast Kluyveromyces drosophilarum: structure and molecular dimorphism. Plasmid (1986) 1.08
Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? Cardiovasc Res (1990) 1.02
Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies. Acta Myol (2011) 1.01
Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease. Am J Cardiol (1993) 1.00
Development of an in-shoe pressure-sensitive device for gait analysis. Conf Proc IEEE Eng Med Biol Soc (2011) 1.00
Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging (2014) 1.00
Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry (2009) 0.99
Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation (1995) 0.99
Apoptosis and aging in mitochondrial morphology mutants of S. cerevisiae. Folia Microbiol (Praha) (2007) 0.98
Skeletal reconstruction with a free vascularized fibula graft associated to bone allograft after resection of malignant bone tumor of limbs. Handchir Mikrochir Plast Chir (2001) 0.97
Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset. Int J Cardiol (1992) 0.97
Predictive value of the El-Ganzouri multivariate risk index for difficult tracheal intubation: a comparison of Glidescope videolaryngoscopy and conventional Macintosh laryngoscopy. Br J Anaesth (2007) 0.97
[A cardiac embolic stroke due to malposition of the pacemaker lead in the left ventricle. A case report]. Ital Heart J Suppl (2000) 0.97
Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol (2007) 0.96
Significance of hyperventilation-induced ST segment depression in patients with coronary artery disease. J Am Coll Cardiol (1989) 0.96
Effects of nifedipine on coronary hemodynamic findings during exercise in patients with stable exertional angina. Circulation (1983) 0.95
An outcome study on complications using routine ultrasound assistance for internal jugular vein cannulation. Acta Anaesthesiol Scand (2007) 0.94
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med (1997) 0.94
The alcohol dehydrogenase system in the yeast, Kluyveromyces lactis. Yeast (1990) 0.93
A gene-cloning system for Kluyveromyces lactis and isolation of a chromosomal gene required for killer toxin production. J Basic Microbiol (1988) 0.93
Heart disease in Turner's syndrome. Helv Paediatr Acta (1988) 0.93
Two-stage reimplantation for periprosthetic knee infection: Influence of host health status and infecting microorganism. Knee (2012) 0.92
Ethanol-induced and glucose-insensitive alcohol dehydrogenase activity in the yeast Kluyveromyces lactis. Mol Microbiol (1992) 0.92
Mitochondrial translation products during release from glucose repression in Saccharomyces cerevisiae. J Bacteriol (1983) 0.92
Soft artificial tactile sensors for the measurement of human-robot interaction in the rehabilitation of the lower limb. Conf Proc IEEE Eng Med Biol Soc (2010) 0.91
Mental arithmetic stress testing in patients with coronary artery disease. Am Heart J (1984) 0.91
Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol (1998) 0.91
Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. J Interv Card Electrophysiol (2001) 0.91
Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context. Nanoscale (2010) 0.90
Development of gait segmentation methods for wearable foot pressure sensors. Conf Proc IEEE Eng Med Biol Soc (2012) 0.90
Significance of exercise-induced ST-segment elevation in patients without myocardial infarction. Circulation (1981) 0.89
Structural and biochemical studies of alcohol dehydrogenase isozymes from Kluyveromyces lactis. Biochim Biophys Acta (1997) 0.89
Prolactin secretion after beer. Lancet (1981) 0.89
[Paroxysmal atrial fibrillation: study of the pattern of onset using dynamic electrocardiography]. Cardiologia (1989) 0.89
Cerebral cortex blood flow and vascular smooth muscle contractility in a rat model of ischemia: a correlative laser Doppler flowmetric and scanning electron microscopic study. Acta Neuropathol (1997) 0.88
Effectiveness of vision rehabilitation treatment through MP-1 microperimeter in patients with visual loss due to macular disease. Clin Ter (2012) 0.88
Isolation and study of KlLSM4, a Kluyveromyces lactis gene homologous to the essential gene LSM4 of Saccharomyces cerevisiae. Yeast (2001) 0.87
[The role of autoimmune mechanisms in the hyperthyroidism-viral hepatitis syndrome: a possible noncausal association. A review of the literature and the authors' own cases]. Minerva Med (1990) 0.87
Pregnancy with an ICD and a documented ICD discharge. Europace (2000) 0.87
Use of the KlADH4 promoter for ethanol-dependent production of recombinant human serum albumin in Kluyveromyces lactis. Appl Environ Microbiol (1999) 0.86
Informational content of mitochondrial DNA from a "low density" petite mutant of yeast. Biochem Biophys Res Commun (1973) 0.86
The treatment of neuroendocrine tumors with long-acting somatostatin analogs: a single center experience with lanreotide autogel. J Endocrinol Invest (2011) 0.86
Reliability and validity of a modified gait scoring system and its use in assessing tibial dyschondroplasia in broilers. Br Poult Sci (2002) 0.86
Increased production of inflammatory cytokines in patients with silent myocardial ischemia. J Am Coll Cardiol (2001) 0.85
Two mitochondrial alcohol dehydrogenase activities of Kluyveromyces lactis are differently expressed during respiration and fermentation. Mol Gen Genet (1995) 0.85
Paroxysmal atrial fibrillation in sleep. Sleep (1997) 0.85
Clinical significance of exercise-induced silent myocardial ischemia in patients with coronary artery disease. J Am Coll Cardiol (1987) 0.85
Allergy and multiple sclerosis: a population-based case-control study. Mult Scler (2009) 0.85
Evaluation by cardiopulmonary exercise test of DDDR versus DDD pacing. Pacing Clin Electrophysiol (1992) 0.84
Disruption of six novel genes from chromosome VII of Saccharomyces cerevisiae reveals one essential gene and one gene which affects the growth rate. Yeast (2000) 0.84
Development and validation of a HPLC-ES-MS/MS method for the determination of glucosamine in human synovial fluid. J Pharm Biomed Anal (2009) 0.84
The exercise test in variant angina: results in 114 patients. Circulation (1981) 0.84
Acute renal failure due to amiodarone-induced hypothyroidism. Clin Nephrol (2009) 0.84
Variable threshold exertional angina in patients with transient vasospastic myocardial ischemia. Repeat exercise test results and therapeutic implications. Am J Cardiol (1983) 0.83
Two genes encoding putative mitochondrial alcohol dehydrogenases are present in the yeast Kluyveromyces lactis. Yeast (1991) 0.83
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart (2002) 0.83
Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. Chest (1995) 0.83
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects. Diabet Med (2001) 0.83
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. J Am Coll Cardiol (1999) 0.83
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart (1999) 0.82
Performance, livability, and carcass yield of slow- and fast-growing chicken genotypes fed low-nutrient or standard diets and raised indoors or with outdoor access. Poult Sci (2008) 0.82
Mitochondrial protein-synthesizing machinery in Saccharomyces cerevisiae grown in different metabolic conditions. Variability of seryl-tRNA and alanyl-tRNA isoacceptor patterns. Eur J Biochem (1979) 0.82
Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm. Pacing Clin Electrophysiol (1994) 0.81
Variable threshold of angina during exercise: a clinical manifestation of some patients with vasospastic angina. Am J Cardiol (1981) 0.81
Abnormal coronary vasoconstriction as a predictor of restenosis after successful coronary angioplasty in patients with unstable angina pectoris. N Engl J Med (1991) 0.81
The neurotrophin receptor p75NTR is induced on mature myofibres in inflammatory myopathies and promotes myotube survival to inflammatory stress. Neuropathol Appl Neurobiol (2012) 0.80
[Coronary spasm on exercise. Demonstration of a case by coronary angiography]. Arch Mal Coeur Vaiss (1978) 0.80
Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man. J Clin Endocrinol Metab (1990) 0.80